Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte Awarded 40th U.S. Patent: Real-time Power Optimization Expands Capabilities

Labcyte, whose Echo® liquid handling platforms move liquids with sound , today announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown.

August 24, 2010

Sunnyvale, CA

Sunnyvale, CA — August 24, 2010 — Labcyte, whose Echo® liquid handling platforms move liquids with sound, today announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte’s acoustic droplet ejection technology offers touchless transfer of a wide variety of fluids, with major benefits in life science applications including drug discovery, genomics, proteomics and diagnostics.

“This new feature—already incorporated in our products—allows customers to transfer liquids for a wide range of applications including siRNA screening, qPCR, genotyping and total assay assembly for drug discovery,” said Rich Ellson, Labcyte CTO. “Customers have chosen Echo liquid handlers because they provide better precision and accuracy, reduce operating costs and eliminate cross-contamination. The technology described in the patent allows users to transfer many different fluids with factory-installed calibrations that require no user customization. By delivering precisely the amount of acoustic energy required the challenges faced by other liquid handling platforms, such as variable surface tension and viscosity, are eliminated. The built-in intelligence of the Echo platform automatically optimizes fluid transfer well by well.”

About Labcyte Inc.
Labcyte Inc. uses sound to move liquids. This eco-friendly, ‘touchless’ technology eliminates the pipette tips used in conventional liquid handlers. Not only does the elimination of pipette tips save hundreds of thousands of dollars in decreased consumables but it provides dramatically better answers as compounds and other materials adsorb to pipette tips during transfer. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other liquid handlers. This technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Labcyte technologies have broad applications including compound management, high-throughput screening, total assay assembly, genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer and are in use by all ten of the top ten pharmaceutical companies. Labcyte, headquartered in Sunnyvale, California, has 40 U.S., 8 European, and two Japanese patents and additional U.S. and international filings. For more information, visit www.labcyte.com.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP